COFFEE: control-free noninvasive fetal chromosomal examination using maternal plasma DNA

Prenatal Diagnosis

Volumn 37, Issue 4, 2017, Pages 336-340

  Sun, Kun ^a,b   Chan, K C Allen ^a,b   Hudecova, Irena ^a,b   Chiu, Rossa W K ^a,b   Lo, Y M Dennis ^a,b   Jiang, Peiyong ^a,b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ALGORITHM; ANEUPLOIDY; ARTICLE; CHROMOSOME 21; CHROMOSOME ANALYSIS; CONTROL FREE NONINVASIVE FETAL CHROMOSOMAL EXAMINATION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC TEST ACCURACY STUDY; DNA SEQUENCE; FALSE POSITIVE RESULT; FEMALE; FETUS; GENETIC ALGORITHM; HUMAN; HUMAN GENOME; MATERNAL PLASMA; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; TRISOMY 21; BLOOD; CHROMOSOME ABERRATION; DNA MUTATIONAL ANALYSIS; METABOLISM; PREGNANCY; PRENATAL DIAGNOSIS; PROCEDURES;

ANEUPLOIDY; CHROMOSOME ABERRATIONS; CYTOGENETIC ANALYSIS; DNA; DNA MUTATIONAL ANALYSIS; FEMALE; FETUS; HUMANS; PREGNANCY; PRENATAL DIAGNOSIS; SEQUENCE ANALYSIS, DNA;

EID: 85013442789     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.5016     Document Type: Article

References (24)

1. Lo YMD, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997;350:485–7.
2. Lo YMD, Hjelm NM, Fidler C, et al. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 1998;339:1734–8.
3. Lo YMD, Lun FMF, Chan KCA, et al. Digital PCR for the molecular detection of fetal chromosomal aneuploidy. Proc Natl Acad Sci U S A 2007;104:13116–21.
4. Chiu RWK, Chan KCA, Gao Y, et al. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci U S A 2008;105:20458–63.
5. Sun K, Jiang P, Chan KCA, et al. Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments. Proc Natl Acad Sci U S A 2015;112:E5503–E5512.
6. Palomaki GE, Kloza EM, Lambert-Messerlian GM, et al. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med 2011;13:913–20.
7. Norton ME, Wapner RJ. Cell-free DNA analysis for noninvasive examination of trisomy. N Engl J Med 2015;373:2582.
8. Bianchi DW, Parker RL, Wentworth J, et al. DNA sequencing versus standard prenatal aneuploidy screening. N Engl J Med 2014;370:799–808.
9. Lun FMF, Tsui NB, Chan KCA, et al. Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on DNA in maternal plasma. Proc Natl Acad Sci U S A 2008;105:19920–5.
10. Lo YMD, Chan KCA, Sun H, et al. Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Sci Transl Med 2010;261ra91.
11. Lam KW, Jiang P, Liao GJ, et al. Noninvasive prenatal diagnosis of monogenic diseases by targeted massively parallel sequencing of maternal plasma: application to β-thalassemia. Clin Chem 2012;58:1467–75.
12. New MI, Tong YK, Yuen T, et al. Noninvasive prenatal diagnosis of congenital adrenal hyperplasia using cell-free fetal DNA in maternal plasma. J Clin Endocrinol Metab 2014;99:E1022–E1030.
13. Chan KCA, Jiang P, Sun K, et al. Second generation noninvasive fetal genome analysis reveals de novo mutations, single-base parental inheritance, and preferred DNA ends. Proc Natl Acad Sci U S A 2016;113:E8159–E8168.
14. Sun K, Jiang P, Chan KCA. The impact of digital DNA counting technologies on noninvasive prenatal testing. Expert Rev Mol Diagn 2015;15:1261–8.
15. Allyse M, Minear MA, Berson E, et al. Non-invasive prenatal testing: a review of international implementation and challenges. Int J Womens Health 2015;7:113–26.
16. Chen EZ, Chiu RWK, Sun H, et al. Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing. PLoS One 2011;6e21791.
17. Chiu RWK, Akolekar R, Zheng YW, et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ 2011;342:c7401.
18. Chan KCA, Zhang J, Hui AB, et al. Size distributions of maternal and fetal DNA in maternal plasma. Clin Chem 2004;50:88–92.
19. Yu SC, Chan KCA, Zheng YW, et al. Size-based molecular diagnostics using plasma DNA for noninvasive prenatal testing. Proc Natl Acad Sci U S A 2014;111:8583–8.
20. Ross MG, Russ C, Costello M, et al. Characterizing and measuring bias in sequence data. Genome Biol 2013;14:R51.
21. Straver R, Sistermans EA, Holstege H, et al. WISECONDOR: detection of fetal aberrations from shallow sequencing maternal plasma based on a within-sample comparison scheme. Nucleic Acids Res 2014;42:e31.
22. Hudecova I, Sahota D, Heung MM, et al. Maternal plasma fetal DNA fractions in pregnancies with low and high risks for fetal chromosomal aneuploidies. PLoS One 2014;9e88484.
23. Lun FMF, Chiu RWK, Sun K, et al. Noninvasive prenatal methylomic analysis by genomewide bisulfite sequencing of maternal plasma DNA. Clin Chem 2013;59:1583–94.
24. Cokus SJ, Feng S, Zhang X, et al. Shotgun bisulphite sequencing of the Arabidopsis genome reveals DNA methylation patterning. Nature 2008;452:215–9.